Australia Intravenous (IV) Equipments Market Overview, 2028

Australia, like many developed nations, has an aging population. With an increasing number of elderly individuals, there is a higher prevalence of chronic diseases and conditions that may require intravenous therapies. IV equipment is crucial in delivering medications and fluids for the management of these health issues. The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is on the rise in Australia. Many of these conditions often necessitate long-term treatments, including intravenous therapies, driving the demand for IV equipment. With advancements in cancer treatments, there is an increasing use of chemotherapy and other intravenous therapies for cancer patients. The demand for IV equipment in oncology units and infusion centers is consequently on the rise. The experience of global public health emergencies, including the COVID-19 pandemic, has underscored the importance of a well-equipped healthcare system. IV equipment is crucial for various aspects of patient care, including fluid resuscitation and supportive therapies during emergencies. Lifestyle-related health conditions, such as diabetes and cardiovascular diseases, are on the rise globally. IV equipment is frequently used in the management of these conditions, contributing to sustained demand. Australia's healthcare system is increasingly moving toward value-based care models, where the emphasis is on achieving better patient outcomes and experiences. IV equipment that aligns with value-based care principles, including cost-effectiveness and improved patient outcomes, is likely to see increased adoption. Government initiatives promoting the adoption of advanced medical technologies in healthcare facilities can drive the demand for modern IV equipment. Funding programs or incentives aimed at upgrading healthcare infrastructure may lead to the acquisition of state-of-the-art IV devices. According to the research report "Australia Intravenous (IV) Equipments Market Overview, 2028," published by Bonafide Research, the Australia IV Equipments market is expected to reach market size of more than USD 350 Million by 2028. Patient safety remains a top priority in Australia's healthcare system. IV equipment with enhanced safety features, such as dose error reduction systems (DERS) and alarms to prevent medication errors, is gaining importance. The emphasis on reducing adverse events and enhancing overall patient safety is influencing the design and functionality of IV devices. The expansion of ambulatory care services, including day surgery centers and outpatient clinics, has implications for the use of IV equipment. Compact and portable IV devices that cater to the needs of ambulatory care settings are becoming more relevant. The use of Closed System Transfer Devices (CSTDs) is increasing, particularly in the administration of hazardous drugs. These devices help minimize the risk of drug exposure to healthcare workers and patients during the handling and administration of certain medications. The use of peripheral intravenous catheters is on the rise. These catheters are commonly used for short-term IV therapy and are favored for their ease of insertion. On-going improvements in PIVC design and materials contribute to patient comfort and safety. Improvements in alarm systems on infusion pumps and IV equipment aim to alert healthcare providers to potential issues promptly. Advanced alarm features help in preventing and addressing situations such as occlusions, air in the line, or other infusion-related problems. The integration of Radio-Frequency Identification (RFID) technology is a trend in IV equipment. RFID tags on IV bags and equipment enable efficient tracking of medication administration, helping to reduce errors and streamline inventory management.

Based on product market is segmented into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Stopcocks and check valves play a critical role in intravenous administration by controlling the flow of fluids and medications. They are essential components in IV lines, allowing healthcare providers to manage the infusion process effectively. Check valves are designed to prevent backflow, ensuring that fluids move in one direction only. This is crucial in preventing contamination and maintaining the integrity of the IV system. Stopcocks and check valves contribute to the safety and reliability of intravenous therapy. The healthcare industry places a strong emphasis on infection control, and the design of stopcocks and check valves often includes features that help minimize the risk of contamination. This focus on patient safety and infection prevention can drive the demand for these components. The precise control of fluids in IV systems is crucial for accurate medication administration and fluid management. Stopcocks and check valves enable healthcare providers to maintain this control, contributing to the effectiveness of intravenous therapies. The integration of stopcocks and check valves with infusion pumps and other IV devices enhances the overall functionality of IV systems. This integration supports seamless fluid management and medication delivery in both hospital and ambulatory care settings. In terms of end user segment market is majorly divided into hospitals, clinics, home care settings and others. Some IV equipment may be tailored for use in specialized healthcare facilities or departments, such as oncology centers, dialysis centers, and fertility clinics. The increasing emphasis on outpatient care and ambulatory services may lead to a growing demand for IV equipment in settings outside traditional hospitals. This could include standalone infusion centers, day procedure centers, and other ambulatory care facilities. With the rise of telemedicine and virtual care, there may be an increased demand for IV equipment in settings where remote monitoring and administration of intravenous therapies are facilitated. Changes in healthcare delivery models, such as the adoption of value-based care or new care coordination approaches, may create demand for specific types of IV equipment tailored to these evolving models. Certain patient populations with unique medical needs, such as pediatric patients, geriatric patients, or patients with rare diseases, may require specialized IV equipment. The "Others" category could capture the demand arising from these populations. Considered in this report: • Geography: Australia • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report: • Australia IV Equipments market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • IV Catheters • Infusion Pumps • Administration Sets • Securement Devices • Needless Connectors • Stopcocks and Check Valves • Drip Chambers • Others By End User: • Hospital • Clinics • Home Care Settings • Others

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Indication: • Cardiovascular Disorders & Hypertension • Pregnancy • Diabetes • Respiratory Diseases • Cancer • Movement Disorders • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the IV Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.